Cambridge Cognition Holdings Plc (AIM:COG)
London · Delayed Price · Currency is GBP · Price in GBX 34.00
0.00 (0.00%)
Oct 31, 2025, 3:12 PM GMT+1
AIM:COG Revenue
Cambridge Cognition Holdings had revenue of 4.32M GBP in the half year ending June 30, 2025, a decrease of -28.55%. This brings the company's revenue in the last twelve months to 9.05M, down -30.77% year-over-year. In the year 2024, Cambridge Cognition Holdings had annual revenue of 10.34M, down -23.48%.
Revenue (ttm)
9.05M
Revenue Growth
-30.77%
P/S Ratio
1.57
Revenue / Employee
107.79K
Employees
84
Market Cap
14.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.34M | -3.17M | -23.48% |
| Dec 31, 2023 | 13.52M | 902.00K | 7.15% |
| Dec 31, 2022 | 12.61M | 2.52M | 24.96% |
| Dec 31, 2021 | 10.09M | 3.35M | 49.74% |
| Dec 31, 2020 | 6.74M | 1.70M | 33.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Cambridge Cognition Holdings News
- 2 months ago - AIM Market Roundup: Cambridge Cognition, Karelian Diamonds, Conroy Gold - The Armchair Trader
- 1 year ago - Small Cap Stocks: Quantum Blockchain, Arkle Resources, Chariot O&G - The Armchair Trader